RaQualia Pharma Inc.
4579.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -¥214,237 | -¥349,532 | -¥5,215 | -¥155,138 |
| Dep. & Amort. | ¥120,855 | ¥119,393 | ¥117,852 | ¥122,558 |
| Deferred Tax | ¥0 | ¥0 | ¥0 | ¥0 |
| Stock-Based Comp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Change in WC | ¥170,935 | ¥272,469 | -¥474,774 | -¥67,900 |
| Other Non-Cash | -¥7,511 | ¥14,725 | ¥60,542 | ¥52,122 |
| Operating Cash Flow | ¥70,042 | ¥57,055 | -¥301,595 | -¥48,358 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -¥14,568 | -¥40,852 | -¥11,444 | ¥210 |
| Net Acquisitions | ¥0 | ¥0 | ¥0 | ¥0 |
| Inv. Purchases | ¥0 | ¥0 | -¥200,000 | ¥0 |
| Inv. Sales/Matur. | ¥200,000 | ¥0 | ¥200,000 | ¥200,000 |
| Other Inv. Act. | -¥3,299 | -¥143 | ¥0 | -¥1,357 |
| Investing Cash Flow | ¥182,133 | -¥40,995 | -¥11,444 | ¥198,853 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -¥147,422 | -¥147,625 | -¥146,230 | -¥146,003 |
| Stock Issued | ¥0 | ¥1,018,707 | ¥0 | ¥0 |
| Stock Repurch. | ¥0 | ¥0 | ¥0 | -¥2 |
| Dividends Paid | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Fin. Act. | ¥0 | -¥1 | -¥50,000 | ¥79,827 |
| Financing Cash Flow | -¥147,422 | ¥871,081 | -¥196,230 | -¥66,178 |
| Forex Effect | ¥15,964 | -¥229,051 | ¥131,764 | ¥57,300 |
| Net Chg. in Cash | ¥120,717 | ¥658,090 | -¥377,505 | ¥141,619 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | ¥3,422,513 | ¥2,764,423 | ¥3,141,928 | ¥3,000,310 |
| End Cash | ¥3,543,230 | ¥3,422,513 | ¥2,764,423 | ¥3,141,929 |
| Free Cash Flow | ¥55,474 | ¥19,518 | -¥313,039 | -¥48,148 |